R/R B-NHL

Clinical trials for R/R B-NHL explained in plain language.

Never miss a new study

Get alerted when new R/R B-NHL trials appear

Sign up with your email to follow new studies for R/R B-NHL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New cell therapy targets tough lymphoma

Disease control Not yet recruiting

This study tests a new treatment called AcNK-Sup003 for people with a type of blood cancer (B-cell non-Hodgkin lymphoma) that has come back or not responded to other treatments. The goal is to see if it is safe and to find the best dose. About 28 adults will take part, and resear…

Matched conditions: R/R B-NHL

Phase: NA • Sponsor: Donghua Zhang • Aim: Disease control

Last updated May 06, 2026 16:13 UTC

R/R B-NHL

Get alerted when new R/R B-NHL trials appear

New cell therapy targets tough lymphoma